Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Cost analysis of glatiramer acetate vs. fingolimod for the treatment of patients with relapsing-remitting multiple sclerosis in Spain.
Measurement of retinal nerve fiber layer thickness in eyes with optic disc swelling by using scanning laser polarimetry and optical coherence tomography.
Cerebrospinal fluid chitinase-3-like 2 and chitotriosidase are potential prognostic biomarkers in early multiple sclerosis.
Association of IL-13 single nucleotide polymorphisms in Iranian patients to multiple sclerosis.
Catatonia and klüver-bucy syndrome in a patient with acute disseminated encephalomyelitis.
Circulating dendritic cells of multiple sclerosis patients are proinflammatory and their frequency is correlated with MS-associated genetic risk factors.
T-bet is essential for Th1-mediated, but not Th17-mediated, CNS autoimmune disease.
Neuropathological Techniques to Investigate Central Nervous System Sections in Multiple Sclerosis.
Regnase-1 in microglia negatively regulates high mobility group box 1-mediated inflammation and neuronal injury.
Clinical and imaging findings in three patients with advanced inflammatory demyelinating polyradiculoneuropathy associated with nerve root hypertrophy.
Reactivity to AQP4 epitopes in relapsing-remitting multiple sclerosis.
Cutting-edge of advanced MRI for demyelinating diseases.
Increased Circulating Levels of Vitamin D Binding Protein in MS Patients.
Oligodendrocyte progenitor programming and reprogramming: Toward myelin regeneration.
Experimental models of neuromyelitis optica.
Cognitive and patient-reported outcomes in adults with pediatric-onset multiple sclerosis.
Tropisetron diminishes demyelination and disease severity in an animal model of multiple sclerosis.
Headaches in multiple sclerosis patients might imply an inflammatorial process.
Significance of gray matter brain lesions in multiple sclerosis and neuromyelitis optica.
Different definitions of neurodegeneration produce similar amyloid/neurodegeneration biomarker group findings.
Is cervical decompression beneficial in patients with coexistent cervical stenosis and multiple sclerosis?
"History had taken such a large piece out of my life" - Neuroscientist refugees from Hamburg during National Socialism.
Hereditary diffuse leukoencephalopathy with spheroids - a volumetric and radiological comparison with multiple sclerosis patients and healthy controls.
Requirement for safety monitoring for approved MS therapies - An overview.
[Targeted Therapy and Progressive Multifocal Leukoencephalopathy (PML): PML in the Era of Monoclonal Antibody Therapies].
Pages
« first
‹ previous
…
605
606
607
608
609
610
611
612
613
…
next ›
last »